CSIR-Centre for Cellular and Molecular Biology, Hyderabad, India.
Infect Genet Evol. 2013 Mar;14:369-74. doi: 10.1016/j.meegid.2012.12.029. Epub 2013 Jan 17.
Interferon beta1 (IFNB1) is a type I interferon that is mainly known for its antiviral activity, but it also regulates a number of anti-inflammatory and immunomodulatory functions. Studies on mouse models of cerebral malaria have established that IFNB1 regulates severe malaria pathogenesis and increases overall survival against malaria. It down-regulates pro-inflammatory cytokines: TNF, IFNG and ICAM-1, resulting in decreased adherence of Plasmodium falciparum parasitized RBC to capillary wall, entry into the brain and delayed onset of death. Therefore, we hypothesized that variations in IFNB1 gene could regulate malarial pathogenesis. We re-sequenced the complete IFNB1 gene along with 900bp of 5' up-stream and 500bp of 3'-UTR in 437 individuals from malaria endemic regions of the Orissa and Chhattisgarh states of India. The subjects comprised of 173 cases of severe malaria, 101 of mild malaria, and 156 ethnically matched asymptomatic controls. Data were statistically compared between cases and controls for their possible association with P. falciparum malarial outcome. Two single nucleotide polymorphisms (SNPs): a synonymous c.153C>T (rs1051922) and a non-synonymous substitution c.102C>G (rs139262191, p.Ser34Arg) were identified. The genotype and allele distribution of c.153C>T did not differ significantly between the study groups [mild, χ(2)2=4.10, p-value<0.13 and severe χ(2)2=0.06, p-value<0.97]. Interestingly, the rare non-synonymous SNP (rs139262191) was observed only in malaria patients. The differences between all cases and controls did not reach statistical significance, however, a statistically significant difference was observed between the asymptomatic control group and the cerebral malaria group [OR=20.32, 95% CI=1.08-382.63, p-value=0.044]. Moreover, the genotypes between cerebral malaria positive and negative groups were not significantly different [OR=5.58, 95% CI=0.61-50.97, p-value=0.123]. Our findings suggest that the IFNB1 variant, p.Ser34Arg, might be a risk factor for cerebral malaria in Indian populations.
干扰素 beta1(IFNB1)是一种 I 型干扰素,主要以其抗病毒活性而闻名,但它也调节许多抗炎和免疫调节功能。对脑型疟疾的小鼠模型的研究表明,IFNB1 调节严重疟疾发病机制并提高抗疟疾的总生存率。它下调促炎细胞因子:TNF、IFNG 和 ICAM-1,从而减少恶性疟原虫寄生 RBC 与毛细血管壁的黏附、进入大脑和延迟死亡的发生。因此,我们假设 IFNB1 基因的变异可以调节疟疾发病机制。我们对来自印度奥里萨邦和恰蒂斯加尔邦疟疾流行地区的 437 个人进行了完整的 IFNB1 基因以及 900bp 上游 5' 和 500bp 下游 3'UTR 的重测序。研究对象包括 173 例严重疟疾、101 例轻度疟疾和 156 例种族匹配的无症状对照。对病例和对照之间的数据进行统计学比较,以确定其与恶性疟原虫疟疾结果的可能关联。发现了两个单核苷酸多态性(SNPs):同义 c.153C>T(rs1051922)和非同义取代 c.102C>G(rs139262191,p.Ser34Arg)。c.153C>T 的基因型和等位基因分布在研究组之间没有显著差异[轻度,χ(2)2=4.10,p 值<0.13;严重,χ(2)2=0.06,p 值<0.97]。有趣的是,罕见的非同义 SNP(rs139262191)仅在疟疾患者中观察到。所有病例和对照之间的差异没有达到统计学意义,但无症状对照组和脑型疟疾组之间存在统计学显著差异[OR=20.32,95%CI=1.08-382.63,p 值=0.044]。此外,脑型疟疾阳性和阴性组之间的基因型没有显著差异[OR=5.58,95%CI=0.61-50.97,p 值=0.123]。我们的研究结果表明,IFNB1 变异体 p.Ser34Arg 可能是印度人群脑型疟疾的危险因素。